Latest filing published 20 Nov 2025 for Lexeo Therapeutics, Inc., €4,919.
Filing timeline
BuySaleInsider track record
Eric Adler: trading record in brief
This profile gathers the share dealings of Eric Adler in Lexeo Therapeutics, Inc. Between 2 February 2024 and 18 November 2025, the trades on record add up to 9 filings.
Sales make up the whole of the open-market record (6 sales, €45k). Outside the open market, there are 3 share grants. 2025 to date brings no purchases and 6 sales.
The newest entry dates from 20 November 2025: an open-market sale of €4,919, in Lexeo Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Eric Adler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 615 shares@ US$9.2726.2% of flowCommon StockSEC:0001994972-25-000005:0
- 9,570 shares0Common StockSEC:0001994972-25-000003:0
- 608 shares@ US$4.66813.0% of flowCommon StockSEC:0001415889-25-022475:0
- 585 shares@ US$2.7747.7% of flowCommon StockSEC:0001415889-25-013818:0
- 2,359 shares@ US$4.41353.1% of flowCommon StockSEC:0001415889-25-005109:0
- 43,750 shares0Common StockSEC:0001415889-25-001283:0
- 26,875 shares0Common StockSEC:0001209191-24-002928:0
7 of 7 declarations
